You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

methodology study, PET Imaging, COPD patients

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cerebral Gliosis, Positron Emission Tomography Trial in Shanghai ([18F]BF3-BPA Injection for PET Imaging)

Recruiting
  • Cerebral Gliosis
  • Positron Emission Tomography
  • [18F]BF3-BPA Injection for PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

Recruiting
  • Hepatocellular Carcinoma
  • [68Ga]Ga-NOTA-RG2 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Prostate Cancer Trial (HRS-9815 injection)

Not yet recruiting
  • Prostate Cancer
  • HRS-9815 injection
  • (no location specified)
Sep 25, 2023

Kidney Cancer, Lymphomas, Positron Emission Tomography Trial in Shanghai ([18F]RCCB6 PET Imaging)

Recruiting
  • Kidney Cancer
  • +2 more
  • [18F]RCCB6 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

Tumors Trial in Beijing ([68Ga]P3)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jul 4, 2023

Tumors Trial in Beijing ([68Ga]P3)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jun 4, 2023

Hyperpolarized Xenon Functional Lung Imaging in COPD Patients

Not yet recruiting
  • COPD
  • Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI
  • (no location specified)
Apr 3, 2023

Prostate Cancer Trial in Nanjing (68Ga-PSMA-33)

Recruiting
  • Prostate Cancer
  • Nanjing, Jiangsu, China
    68Ga-PSMA-33 PET/CT imaging
Sep 19, 2023

Aldosterone-Producing Adenoma Trial (CXCR4)

Not yet recruiting
  • Aldosterone-Producing Adenoma
  • CXCR4
  • (no location specified)
Apr 20, 2023

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)

Not yet recruiting
  • Multiple Myeloma
  • Plasma Cell Myeloma
  • Zirconium Zr 89-DFO-YS5
  • +3 more
  • San Francisco, California
    University of California, San Francisco
May 26, 2023

Healthy Trial (Siemens Quadra PET/CT and [18F]FDG, Apple i-Watch)

Not yet recruiting
  • Healthy
  • Siemens Quadra PET/CT and [18F]FDG
  • Apple i-Watch
  • (no location specified)
Jun 30, 2023

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
May 3, 2023

Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)

Recruiting
  • Prostate Cancer
  • [18F]Florastamin Injection
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Aug 21, 2023

Breast Cancer Female, Breast Cancer Recurrent Trial in Drammen (18F-FDG PET/CT)

Recruiting
  • Breast Cancer Female
  • Breast Cancer Recurrent
  • 18F-FDG PET/CT
  • Drammen, Norway
    Drammen Hospital - Vestre Viken HF
Feb 17, 2023

Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and

Not yet recruiting
  • Von Hippel-Lindau Disease
  • 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
  • (no location specified)
Mar 30, 2023

Rectal Cancer Trial in Wuhan (68Ga-FAPI-04, 18F-FDG)

Recruiting
  • Rectal Cancer
  • Wuhan, Hubei, China
    China, Hubei Province
Aug 11, 2023

18F-0502B PET Imaging Targeting a-synuclein in Diagnosis of

Recruiting
  • Positron-Emission Tomography
  • Alpha Synuclein Pathology
    • Shanghai, China
      Huashan Hospital
    Mar 13, 2023

    A Study of Metabolic Agents Following Brain Radiation

    Enrolling by invitation
    • CNS Malignancy
    • F-DOPA Positron Emission Tomography
    • Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
    • Rochester, Minnesota
      Mayo Clinic
    Nov 21, 2023

    Tumors Trial in Beijing ([68Ga]N188)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jan 27, 2023

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

      Not yet recruiting
      • Hypercholesterolemia
      • +3 more
      • Cambridge, United Kingdom
        University of Cambridge
      Jan 13, 2023

      Multiple Sclerosis, Inflammatory Demyelinating Disease Trial in Rochester (C-11 ER176 Radiotracer, C11 Pittsburgh Compound B,

      Not yet recruiting
      • Multiple Sclerosis
      • Inflammatory Demyelinating Disease
      • C-11 ER176 Radiotracer
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic Minnesota
      Mar 28, 2023